Regarding progress in brain-computer interfaces, Yingkang Life recently stated during a roadshow that the company focuses on the field of brain science, is guided by clinical value, and is continuing to build an innovative application platform for brain science around five major diseases, including Parkinson's disease and Alzheimer's disease. In terms of technical capabilities, the company has established a management plan covering the entire process of DBS surgery and promoted the replication of this technology within the system. Sichuan Friendship Hospital and Qingdao Yinghai Hospital were each selected on the list of national cooperative medical institutions for SCAN loop stimulation treatment for Parkinson's disease. In the future, the company will keep up with changes in industrial policies and clinical needs, and carefully evaluate the viability and pace of the industrial chain layout according to business development needs. Currently, related businesses are still in the early clinical stages, and there is no significant impact on the company's short-term performance. Investors are requested to pay attention to investment risks.

Regarding progress in brain-computer interfaces, Yingkang Life recently stated during a roadshow that the company focuses on the field of brain science, is guided by clinical value, and is continuing to build an innovative application platform for brain science around five major diseases, including Parkinson's disease and Alzheimer's disease. In terms of technical capabilities, the company has established a management plan covering the entire process of DBS surgery and promoted the replication of this technology within the system. Sichuan Friendship Hospital and Qingdao Yinghai Hospital were each selected on the list of national cooperative medical institutions for SCAN loop stimulation treatment for Parkinson's disease. In the future, the company will keep up with changes in industrial policies and clinical needs, and carefully evaluate the viability and pace of the industrial chain layout according to business development needs. Currently, related businesses are still in the early clinical stages, and there is no significant impact on the company's short-term performance. Investors are requested to pay attention to investment risks.